|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Strategies to reduce pulmonary complications after esophagectomy显示文摘Esophagectomy,the surgical removal of all or part of the esophagus,is a surgical procedure that is associated with high morbidity and mortality.Pulmonary complications are an especially important postoperative problem.Therefore,many perioperative strategies to prevent pulmonary complications after esophagectomy have been investigated and introduced in daily clinical practice.Here,we review these strategies,including improvement of patient performance and technical advances such as minimally invasive surgery that have been implemented in recent years.Furthermore,interventions such as methylprednisolone,neutrophil elastase inhibitor and epidural analgesia,which have been shown to reduce pulmonary complications,are discussed.Benefits of the commonly applied routine nasogastric decompression,delay of oral intake and prophylactic mechanical ventilation are unclear,and many of these strategies are also evaluated here.Finally,we will discuss recent insights and new developments aimed to improve pulmonary outcomes after esophagectomy. | Teus J Weijs Jelle P Ruurda Grard AP Nieuwenhuijzen Richard van Hillegersberg Misha DP Luyer | 2013 | World Journal of Gastroenterology2013，19，39： | 17 |
| 2 | RTOG 0211:a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients显示文摘PURPOSE: To determine the safety and efficacy of gefitinib,an epidermal growth factor receptor(EGFR) tyrosine kinase inhibitor,in combination with radiation for newly diagnosed glioblastoma(GBM) patients.METHODS AND MATERIALS: Between March 21,2002,and May 3,2004,Radiation Therapy Oncology Group(RTOG) 0211 enrolled 31 and 147GBM patients in the phase 1 and 2 arms,respectively.Treatment consisted of daily oral gefinitnib started at the time of conventional cranial radiation therapy(RT) and continued post RT for 18 months or until progression.Tissue microarrays from 68 cases were analyzed for EGFR expression.RESULTS: The maximum tolerated dose(MTD) of gefitinib was determined to be 500 mg in patients on non-enzyme-inducing anticonvulsant drugs(non-EIAEDs).All patients in the phase 2 component were treated at a gefitinib dose of 500 mg;patients receiving EIADSs could be escalated to 750 mg.The most common side effects of gefitinib in combination with radiation were dermatologic and gastrointestinal.Median survival was 11.5 months for patients treated per protocol.There was no overall survival benefit for patients treated with gefitinib + RT when compared with a historical cohort of patients treated with RT alone,matched by RTOG recursive partitioning analysis(RPA) class distribution.Younger age was significantly associated with better outcome.Per protocol stratification,EGFR expression was not found to be of prognostic value for gefitinib + RT-treated patients.CONCLUSIONS: The addition of gefitinib to RT is well tolerated.Median survival of RTOG 0211 patients treated with RT with concurrent and adjuvant gefitinib was similar to that in a historical control cohort treated with radiation alone. | Chakravarti A Wang M Robins HI Lautenschlaeger T Curran WJ Brachman DG Schultz CJ Choucair A Dolled-Filhart M Christiansen J Gustavson M Molinaro A Mischel P Dicker AP Bredel M Mehta M | 2013 | 中国神经肿瘤杂志2013，11，1： | 8 |
| 3 | 固定低剂量三联抗高血压药物与常规治疗对斯里兰卡轻度至中度高血压患者血压控制的疗效差异:一项随机临床试验显示文摘控制不良的高血压是全球领先的公共卫生问题,需要新的治疗策略。该研究评估低剂量三联抗高血压药物治疗是否能达到比常规治疗更好的血压控制。研究者纳入2016年2月至2017年5月在斯里兰卡11所城市医院诊所就诊的需要开始抗高血压治疗(未治疗的患者)或接受单药治疗的患者,进行低剂量三联降压与常规治疗比较的随机、开放性试验,随访至2017年10月。 | Web-ster R Salam A de Silva HA Selak V Stepien S Rajapakse S Amarasekara S Amarasena N Billot L de Silva AP Fernando M Guggilla R Jan S Jayawardena J Maulik PK Mendis S Munasinghe J Naik N Prabhakaran D Ranasinghe G Thom S Tisserra N Senaratne V Wijekoon S Wijeyasingam S Rodgers A Patel A 刘莉 叶鹏 | 2018 | 中华高血压杂志2018，26，12： | 7 |
| 4 | Propylthiouracyl-induced severe liver toxicity:An indication for alanine aminotransferase monitoring?显示文摘Propylthiouracyl (PTU)-related liver toxicity is likely to oc- cur in about 1% of treated patients. In case of acute or subacute hepatitis, liver failure may occur in about one third. We report two further cases of PTU-induced sub- acute hepatitis, in whom the delay between occurrence of liver damage after the initiation of treatment, the un- derestimation of its severity and the delayed withdrawal of the drug were all likely responsible for liver failure. The high incidence of liver toxicity related to PTU, its potential severity and delayed occurrence after initiation of treatment are in favor of monthly alanine aminotrans- ferase monitoring, at least during the first six months of therapy. | M Benyounes C Sempoux C Daumerie J Rahier AP Geubel | 2006 | World Journal of Gastroenterology2006，12，38： | 3 |
| 5 | Diagnostic value of drain amylase for detecting intrathoracic leakage after esophagectomy显示文摘AIM:To investigate the value of elevated drain amylase concentrations for detecting anastomotic leakage(AL) after minimally invasive Ivor-Lewis esophagectomy(MIILE).METHODS:This was a retrospective analysis of prospectively collected data in two hospitals in the Netherlands. Consecutive patients undergoing MI-ILE were included. A Jackson-Pratt drain next to the dorsal side of the anastomosis and bilateral chest drains were placed at the end of the thoracoscopic procedure. Amylase levels in drain fluid were determined in all patients during at least the first four postoperative days. Contrast computed tomography scans and/or endoscopic imaging were performed in cases of a clinically suspected AL. Anastomotic leakage was defined as any sign of leakage of the esophago-gastric anastomosis on endoscopy,re-operation,radiographic investigations,post mortal examination or when gastro-intestinal contents were found in drain fluid. Receiver operator characteristic curves were used to determine the cut-off values. Sensitivity,specificity,positive predictive value,negative predictive value,risk ratio and overall test accuracy were calculated for elevated drain amylase concentrations.RESULTS:A t o t a l o f 8 9 p a t ie n t s w e re in c lu d e d between March 2013 and August 2014. No differences in group characteristics were observed between patients with and without AL,except for age. Patients with AL were older than were patients without AL(P = 0.01). One patient(1.1%) without AL died within 30 d after surgery due to pneumonia and acute respiratory distress syndrome. Anastomotic leakage that required any intervention occurred in 15 patients(16.9%). Patients with proven anastomotic leakage had higher drain amylase levels than patients without anastomotic leakage [median 384 IU/L(IQR 34-6263) vs median 37 IU/L(IQR 26-66),P = 0.003]. Optimal cut-off values on postoperative days 1,2,and 3 were 350 IU/L,200 IU/L and 160 IU/L,respectively. An elevated amylase level was found in 9 of the 15 patients with AL. Five of these 9 patients had early elevations of their amylase levels,with a median of 2 d(IQR 2-5) before signs and symptoms occurred.CONCLUSION:Measurement of drain amylase levels is an inexpensive and easy tool that may be used to screen for anastomotic leakage soon after MI-ILE. However,clinical validation of this marker is necessary. | Gijs HK Berkelmans Ewout A Kouwenhoven Boudewijn JJ Smeets Teus J Weijs Luis C Silva Corten Marc J van Det Grard AP Nieuwenhuijzen Misha DP Luyer | 2015 | World Journal of Gastroenterology2015，21，30： | 3 |
| 6 | 老年高血压和糖尿病患者的死亡率和大血管风险:强化药物治疗的效果显示文摘本研究是为了确定强化药物治疗(intensive drug therapy,IDT)对年龄≥65岁患有2型糖尿病(type 2diabetes mellitus,T2DM)和高血压的患者全因死亡、充血性心力衰竭(congestive heart failure,CHF)、因心肌梗死住院与脑卒中或短暂性脑缺血发作(transient ischemic attack,TIA)的影响。方法:研究对象为来自美国医疗保险数据库的高血压和T2DM患者。采用倾向评分匹配方法对非强化药物治疗组和IDT组进行匹配。使用Cox比例风险模型计算HR。结果:IDT与增加的CHF(HR=2.32,95%CI2.32~2.38)、心肌梗死(HR=4.27,95%CI 4.05~4.52)和脑卒中或TIA(HR=1.80,95%CI 1.70~1.89)风险相关,但也与降低的死亡风险(HR=0.95;95%CI 0.93~0.97)相关。遵循糖尿病管理指南治疗可降低CHF(HR=0.73,95%CI 0.71~0.73)、心肌梗死(HR=0.64,95%CI 0.62~0.67)、脑卒中或TIA(HR=0.82,95%CI 0.78~0.86)和死亡(HR=0.29,95%CI 0.28~0.29)的风险。结论:在高危人群中使用IDT可延缓死亡的发生,但不影响严重大血管病变的发生。IDT对高危患者的保护作用所带来的益处超过多药治疗产生的不良健康问题。 | Yashkin AP Kravchenko J Yashin AI Sloan F 陈云(编译) 叶鹏(审校) | 2018 | 中华高血压杂志2018，26，12： | 2 |
| 7 | 强化与标准降压治疗对脑卒中亚型的影响显示文摘在收缩压干预试验(systolic blood pressure intervention trial, SPRINT)中,各治疗组的脑卒中发生比例差异无统计学意义,但脑卒中亚型的病因不同,可能对强化降压治疗的反应不同。SPRINT纳入患者(n=9 361)随机分为目标收缩压<120 mm Hg(1 mm Hg=0.133 kPa)的强化治疗与目标收缩压<140 mm Hg的标准治疗组。 | Wright CB Auchus AP Lerner A Ambrosius WT Ay H Bates JT Chen J Meschia JF Pancholi S Papademetriou V Rastogi A Sweeney M Willard JJ Yee J Oparil S 赵狄(摘译) 郑武洪(审校) | 2021 | 中华高血压杂志2021，29，3： | 2 |
| 8 | Human Stem/Progenitor Cells from Bone Marrow Enhance Glial Differentiation of Rat Neural Stem Cells: a Role for TGFbeta and Notch Signaling显示文摘 | Robinson AP Foraker J, Ylostalo J Prockop D. | 2010 | 中华神经外科疾病研究杂志2010，9，4： | 2 |
| 9 | Innate immunity of the sinonasal cavity: expression of messenger RNA for complement cascade components and toll-like receptors显示文摘 | Vandermeer J Sha Q Lane AP | 2004 | Arch Otolaryngol Head Neck Surg2004，130，12： | 1 |
| 10 | The waiting game:bridging to paediatric heart transplantation 显示文摘 | Cassidy J de Leval M | 2003 | Lancet2003，362，9400： | 1 |
| 11 | Physiological migra- tion of hematopoietic stem and progenitor cells显示文摘 | Wright DE Wagers A J Gulati AP | 2001 | Science2001，294，5548： | 1 |
| 12 | Arterial compliance and blood pressure显示文摘 | Marchais S J Guerin AP Pannier B | 1993 | Drugs1993，46，2： | 1 |
| 13 | Expression of pituitarytumor transforming gene in colorectal tumors 显示文摘 | Heaney AP Singson R McCabe C J | 2000 | Lancet2000，355，： | 1 |
| 14 | Residents Perceptions on Tourism Impacts显示文摘 | AP J | 1992 | Annals of Tourism Research1992，19，4： | 1 |
| 15 | Oral versus intravenous ganciclovir for the prophylaxis of cytomegalovirus disease after allogeneic bone marrow transplantation显示文摘 | Szer J Durrant S Schwarer AP | 2004 | Intern Med J2004，34，3： | 1 |
| 16 | A randomized con- trolled trial investigating the efficiency of musculoskeletal physiotherapy on chronic low back disorder 显示文摘 | Goldby L J Moore AP Doust J | 2006 | Spine2006，31，10： | 1 |
| 17 | Distinct differentiation potential of 'MSC' derived from cord blood and umbilical cord: are cord-derived cells true mesenchymal stromal cells? 显示文摘 | Bosch J Houben AP Radke TF | 2012 | Stem cells and development2012，21，11： | 1 |
| 18 | Intracellular signaling mechanisms in photodynamic therapy显示文摘 | Almeida RD Manadas B J Carvalho AP | 2004 | Biochem Bio- phys Acta2004，1704，2： | 1 |
| 19 | Effects of epileptiform EEG discharges on cognitive function: is the concept of 'transient cognitive impairment' still valid ? 显示文摘 | Aldenkamp AP Arends J | 2004 | Epilepsy Behav2004，5，1： | 1 |
| 20 | Managerial Learning in the Transformation of Eastern Europe: Some Key Issues显示文摘 | Child J Czegledy AP | 1996 | Organization Studies1996，1，17： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员